Precision BioSciences Inc... (DTIL)
Precision BioSciences Statistics
Share Statistics
Precision BioSciences has 10.48M shares outstanding. The number of shares has increased by 51.35% in one year.
| Shares Outstanding | 10.48M |
| Shares Change (YoY) | 51.35% |
| Shares Change (QoQ) | 36.64% |
| Owned by Institutions (%) | 56.45% |
| Shares Floating | 7.67M |
| Failed to Deliver (FTD) Shares | 348 |
| FTD / Avg. Volume | 0.23% |
Short Selling Information
The latest short interest is 752.7K, so 7.18% of the outstanding shares have been sold short.
| Short Interest | 752.7K |
| Short % of Shares Out | 7.18% |
| Short % of Float | 7.26% |
| Short Ratio (days to cover) | 3.88 |
Valuation Ratios
The PE ratio is 3.63 and the forward PE ratio is -1.01. Precision BioSciences's PEG ratio is -0.03.
| PE Ratio | 3.63 |
| Forward PE | -1.01 |
| PS Ratio | 0.38 |
| Forward PS | 0.6 |
| PB Ratio | 0.46 |
| P/FCF Ratio | -0.44 |
| PEG Ratio | -0.03 |
Enterprise Valuation
Precision BioSciences has an Enterprise Value (EV) of -58.55M.
| EV / Sales | -0.85 |
| EV / EBITDA | -4.33 |
| EV / EBIT | 1 |
| EV / FCF | 1 |
Financial Position
The company has a current ratio of 6.34, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.34 |
| Quick Ratio | 6.34 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.1 |
| Debt / FCF | -0.02 |
| Interest Coverage | 4.02 |
Financial Efficiency
Return on Equity is 12.71% and Return on Invested Capital is 5.78%.
| Return on Equity | 12.71% |
| Return on Assets | 5.25% |
| Return on Invested Capital | 5.78% |
| Revenue Per Employee | $636.07K |
| Profits Per Employee | $66.36K |
| Employee Count | 108 |
| Asset Turnover | 0.5 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -43.39% in the last 52 weeks. The beta is 1.58, so Precision BioSciences's price volatility has been higher than the market average.
| Beta | 1.58 |
| 52-Week Price Change | -43.39% |
| 50-Day Moving Average | 5.08 |
| 200-Day Moving Average | 7.1 |
| Relative Strength Index (RSI) | 55.37 |
| Average Volume (20 Days) | 152.75K |
Income Statement
In the last 12 months, Precision BioSciences had revenue of 68.7M and earned 7.17M in profits. Earnings per share was 1.05.
| Revenue | 68.7M |
| Gross Profit | 68.7M |
| Operating Income | 7.17M |
| Net Income | 7.17M |
| EBITDA | 13.53M |
| EBIT | 8.95M |
| Earnings Per Share (EPS) | 1.05 |
Balance Sheet
The company has 85.9M in cash and 1.32M in debt, giving a net cash position of 84.58M.
| Cash & Cash Equivalents | 85.9M |
| Total Debt | 1.32M |
| Net Cash | 84.58M |
| Retained Earnings | -482.46M |
| Total Assets | 136.39M |
| Working Capital | 80.01M |
Cash Flow
In the last 12 months, operating cash flow was -58.45M and capital expenditures -250K, giving a free cash flow of -58.7M.
| Operating Cash Flow | -58.45M |
| Capital Expenditures | -250K |
| Free Cash Flow | -58.7M |
| FCF Per Share | -8.59 |
Margins
Gross margin is 100%, with operating and profit margins of 10.43% and 10.43%.
| Gross Margin | 100% |
| Operating Margin | 10.43% |
| Pretax Margin | 10.43% |
| Profit Margin | 10.43% |
| EBITDA Margin | 19.69% |
| EBIT Margin | 10.43% |
| FCF Margin | -85.44% |
Dividends & Yields
DTIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 27.53% |
| FCF Yield | -225.46% |
Analyst Forecast
The average price target for DTIL is $34, which is 540.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $34 |
| Price Target Difference | 540.3% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Feb 14, 2024. It was a backward split with a ratio of 1:30.
| Last Split Date | Feb 14, 2024 |
| Split Type | backward |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | -3.08 |
| Piotroski F-Score | 5 |